There are 203 resources available
68P - Adjuvant effect of maraviroc in combination with cisplatin on tumor growth and survival in a murine model of gastric cancer
Presenter: Priscilla Brebi
Session: Poster Display & Cocktail
Resources:
Abstract
69P - Development and characterization of a terbium-161 radioconjugate for selective targeting of carbonic anhydrase IX in hypoxic colorectal tumors
Presenter: Charlotte Segers
Session: Poster Display & Cocktail
Resources:
Abstract
70P - Investigating baicalin and resveratrol as PIM-1 kinase inhibitors for therapeutic targeting of prostate and breast cancers
Presenter: Aanchal Rathi
Session: Poster Display & Cocktail
Resources:
Abstract
71P - LX-101: A novel, clinical stage, payload-bearing targeted therapy directed to the insulin-like growth factor receptor (IGF-1R), demonstrates potent preclinical anti-tumor activity against multiple cancer types with elevated IGF-1R expression
Presenter: Peter McDonald
Session: Poster Display & Cocktail
Resources:
Abstract
72P - Drug repurposing screen for targeting KRAS- and BRAF-mutant colorectal cancer cells
Presenter: Sura Atatri
Session: Poster Display & Cocktail
Resources:
Abstract
73P - Combined cellular and biochemical profiling of BTK inhibitor nemtabrutinib reveals potential application in MAPK pathway-driven cancers
Presenter: Guido Zaman
Session: Poster Display & Cocktail
Resources:
Abstract
74P - A phase I study for safety, tolerability, pharmacokinetics, and anti-tumor activity of ABM-1310 in patients (pts) with BRAF V600 mutation-positive solid tumors: The final result
Presenter: Jin Li
Session: Poster Display & Cocktail
Resources:
Abstract
75P - Apatinib plus hepatic arterial infusion chemotherapy for hepatocellular carcinoma with extrahepatic metastasis
Presenter: Shiguang Chen
Session: Poster Display & Cocktail
Resources:
Abstract
76P - Fruquintinib combined with sintilimab plus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (uHCC): A single-arm phase II study
Presenter: Hui Zeng
Session: Poster Display & Cocktail
Resources:
Abstract
77P - Surufatinib as third- or later-line treatment for patients with advanced small cell lung cancer
Presenter: lin li
Session: Poster Display & Cocktail
Resources:
Abstract